Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00603551 · ClinicalTrials.gov registry record
Screening of Bone Mineral Density in Women Who Have Received Chemotherapy
A clinical trial, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 106
- Enrollment target
NCT00603551: Completed study, sponsored by Medical University of South Carolina.
NCT00603551 is a clinical trial that has completed, run by Medical University of South Carolina. The registered enrollment target is 106 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00603551 has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 106 participants
- Enrollment target
Study Summary
The hypothesis is that postmenopausal women who have received chemotherapy have a greater bone loss than the same age controls. The aim of this study is to obtain baseline bone mineral density (BMD) data on women with breast and gynecological cancers who have received chemotherapy. By comparing the Z scores of postmenopausal women who have received chemotherapy with age matched controls this hypothesis can be evaluated. Another goal of the study is to compare the T-score of a Heel Bone Density Scan to the T-score of the DXA Scan to see if there is a good correlation between peripheral and DXA scores.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2006-11 |
| Est. Completion | 2009-12 |
What the finished NCT00603551 record still lists
NCT00603551 is an observational study that tracks outcomes without assigning an intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00603551 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00603551 about?
NCT00603551 is a clinical study titled "Screening of Bone Mineral Density in Women Who Have Received Chemotherapy". The hypothesis is that postmenopausal women who have received chemotherapy have a greater bone loss than the same age controls. The aim of this study is to obtain baseline bone mineral density (BMD) data on women with breast and gynecological cancers who have received chemotherapy. By comparing the ...
What is the current status of trial NCT00603551?
This trial is currently completed. The enrollment target is 106 participants. The study started on 2006-11. Estimated completion is 2009-12.
Who is sponsoring clinical trial NCT00603551?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia